INS and polycystic ovary syndrome: The nutraceutical may also benefit infertile patients suffering from polycystic ovary syndrome who present distinct changes in the proteome profile of endometrial tissue (Amjadi et al., 2018) and abnormal homocysteine metabolism (Li et al., 2018) related to oxidative stress, inflammation and insulin resistance (Legro et al., 2007).